Godavari Drugs Limited (GODAVARI.BO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-172.8%

-₹93.93

vs ₹129.00 price

Levered DCF

-₹231.57

After debt service

Piotroski score

2 / 9

Weak

Altman Z-score

—

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
P/E	15.84×	15.72×	13.18×	15.06×	9.38×	8.35×	4.34×	14.53×
P/B	0.85×	1.59×	1.88×	1.71×	1.66×	1.41×	0.43×	0.96×
P/S	0.61×	0.61×	0.47×	0.36×	0.31×	0.28×	0.09×	0.21×
EV / EBITDA	12.28×	10×	10.1×	10.3×	6.06×	6.32×	5.94×	7.89×
Gross margin	19.1%	21.4%	22.9%	19.8%	9.7%	21.3%	19.9%	22.3%
Operating margin	7.4%	8.3%	7.3%	6.4%	6.0%	7.0%	5.1%	5.3%
Net margin	3.9%	3.9%	3.5%	2.4%	3.3%	3.4%	2.1%	1.4%
Current ratio	1.31×	1.08×	1.08×	1.18×	1.29×	1.34×	1.19×	1.22×
Debt / equity	1.01×	1.42×	1.48×	1.72×	0.78×	1.25×	1.36×	1.21×
Interest coverage	1.98×	1.98×	2.33×	2.61×	3.39×	2.6×	1.67×	1.52×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Return on equity	5.4%	10.1%	14.2%	11.3%	17.7%	16.9%	9.9%	6.6%
Return on invested capital	4.1%	6.8%	9.3%	8.4%	13.1%	11.0%	8.7%	7.3%
Return on assets	2.0%	3.1%	4.1%	3.1%	5.2%	4.5%	2.4%	1.6%
Free cash flow yield	-46.3%	-19.7%	7.1%	6.9%	12.2%	-1.0%	-7.4%	6.4%
Earnings yield	6.3%	6.4%	7.6%	6.6%	10.7%	12.0%	23.0%	6.9%
Enterprise value	₹1.3B	₹1.3B	₹1.3B	₹1.1B	₹700.5M	₹647.2M	₹358.6M	₹392.3M
Net debt / EBITDA	6×	4.63×	4.34×	5.02×	1.8×	2.96×	4.5×	4.37×
Cash conversion cycle (days)	202	136	107	121	44	80	80	72